Publications by authors named "Vilasack Thammavongsa"

Article Synopsis
  • - Low and very-low-birth-weight (V/LBW) neonates are at a high risk for severe bacterial infections, particularly from Staphylococcus aureus, leading to serious health issues or death.
  • - Previous attempts to use antibody-based treatments to protect these neonates have failed, largely due to the immature immune system, without considering the role of Staphylococcal protein A (SpA) in evading immune responses.
  • - The study introduces monoclonal antibody 3F6, which blocks SpA and enhances the immune response in neonates by promoting better bacterial clearance through phagocytosis, indicating potential for effective antibody treatments.
View Article and Find Full Text PDF

Host immunity against bacteria typically involves antibodies that recognize the microbial surface and promote phagocytic killing. Methicillin-resistant Staphylococcus aureus (MRSA) is a frequent cause of lethal bloodstream infection; however, vaccines and antibody therapeutics targeting staphylococcal surface molecules have thus far failed to achieve clinical efficacy. S.

View Article and Find Full Text PDF

Staphylococcus aureus, a bacterial commensal of the human nares and skin, is a frequent cause of soft tissue and bloodstream infections. A hallmark of staphylococcal infections is their frequent recurrence, even when treated with antibiotics and surgical intervention, which demonstrates the bacterium's ability to manipulate innate and adaptive immune responses. In this Review, we highlight how S.

View Article and Find Full Text PDF
Article Synopsis
  • * A new mouse monoclonal antibody, SpAKKAA-mAb 3F6, has been developed to target and neutralize a specific protein from S. aureus that aids in immune evasion, showing promise in protecting neonatal mice from sepsis and helping them build immunity.
  • * Researchers have created a humanized version of this antibody, which has also demonstrated protective effects in neonatal mice and is set to be tested in clinical trials for VLBW infants.
View Article and Find Full Text PDF

Bacterial invasion of host tissues triggers polymorphonuclear leukocytes to release DNA [neutrophil extracellular traps (NETs)], thereby immobilizing microbes for subsequent clearance by innate defenses including macrophage phagocytosis. We report here that Staphylococcus aureus escapes these defenses by converting NETs to deoxyadenosine, which triggers the caspase-3-mediated death of immune cells. Conversion of NETs to deoxyadenosine requires two enzymes, nuclease and adenosine synthase, that are secreted by S.

View Article and Find Full Text PDF
Article Synopsis
  • Staphylococcus aureus causes recurring skin and soft tissue infections that can progress to serious conditions like sepsis, contributing significantly to infectious disease-related deaths globally.
  • The immune system struggles to mount a protective response against S. aureus infections, partly due to the pathogen's clever strategies to evade immunity.
  • This paper reviews three key secreted proteins (SpA, Sbi, and AdsA) that help S. aureus escape immune detection and explores how these proteins could be targeted for new vaccines and treatments.
View Article and Find Full Text PDF

Background: Staphylococcus aureus is a human pathogen that produces extracellular adenosine to evade clearance by the host immune system, an activity attributed to the 5'-nucleotidase activity of adenosine synthase (AdsA). In mammals, conversion of adenosine triphosphate to adenosine is catalyzed in a two-step process: ecto-nucleoside triphosphate diphosphohydrolases (ecto-NTDPases) hydrolyze ATP and ADP to AMP, whereas 5'-nucleotidases hydrolyze AMP to adenosine. NTPDases harbor apyrase conserved regions (ACRs) that are critical for activity.

View Article and Find Full Text PDF

Residue 116 of major histocompatibility complex (MHC) class I heavy chains is an important determinant of assembly, that can influence rates of ER-Golgi trafficking, binding to the transporter associated with antigen processing (TAP), tapasin dependence of assembly, and the efficiency and specificity of peptide binding. Here, we investigated assembly and peptide-binding differences between HLA-B*3501(S116) and HLA-B*3503(F116), two alleles differing only at position 116 of the MHC class I heavy chain, that are associated respectively with normal or rapid AIDS progression. A reduced intracellular maturation rate was observed for HLA-B*3503 in HIV-infected and uninfected cells, which correlated with enhanced binding of HLA-B*3503 to TAP.

View Article and Find Full Text PDF
Article Synopsis
  • Staphylococcus aureus is a major cause of bacteremia in both hospitalized and healthy individuals, with treatment challenges arising from methicillin resistance.
  • The study highlights adenosine synthase A (AdsA) as a key virulence factor that helps S. aureus evade the immune system by converting adenosine monophosphate to adenosine.
  • The ability to synthesize adenosine was shown to facilitate the escape from immune responses not only in S. aureus but also in Bacillus anthracis, indicating a broader strategy among bacteria to utilize adenosine for immune evasion.
View Article and Find Full Text PDF

A single residue polymorphism distinguishes HLA-B*4402(D116) from HLA-B*4405(Y116), which was suggested to allow HLA-B*4405 to acquire peptides without binding to tapasin-TAP complexes. We show that HLA-B*4405 is not inherently unable to associate with tapasin-TAP complexes. Under conditions of peptide deficiency, both allotypes bound efficiently to TAP and tapasin, and furthermore, random nonamer peptides conferred higher thermostability to HLA-B*4405 than to HLA-B*4402.

View Article and Find Full Text PDF

Calnexin is an endoplasmic reticulum chaperone that binds to substrates containing monoglucosylated oligosaccharides. Whether calnexin can also directly recognize polypeptide components of substrates is controversial. We found that calnexin displayed significant conformational lability for a chaperone and that heat treatment and calcium depletion induced the formation of calnexin dimers and higher order oligomers.

View Article and Find Full Text PDF

It is widely believed that the chaperone activity of calreticulin is mediated by its ability to bind glycoproteins containing monoglucosylated oligosaccharides. However, calreticulin is also a polypeptide binding protein. Here we show that heat shock, calcium depletion, or deletion of the C-terminal acidic domain enhance binding of purified calreticulin to polypeptide substrates and enhance calreticulin's chaperone activity.

View Article and Find Full Text PDF